Barclays’s Dynavax Technologies DVAX Stock Holding History

Barclays’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-121,500	Closed	-$1.85M	–	7174
2018 Q2	$1.85M	Hold	121,500	–	–	﹤0.01%	2649
2018 Q1	$2.41M	Buy	+121,500	New	+$2.1M	﹤0.01%	2291
2016 Q4	–	Sell	-128,900	Closed	-$1.35M	–	6647
2016 Q3	$1.35M	Buy	+128,900	New	+$1.85M	﹤0.01%	2343

Other funds holding DVAX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Barclays's DVAX Position: Q1 2026 in Review

Barclays sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 317,848 shares — an estimated $4.89M sold.

Barclays first reported a position in DVAX in Q2 2013 and held it in 48 quarters. The position peaked at $5.63M in Q4 2023. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

Barclays reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
Barclays sold 317,848 Dynavax Technologies shares in Q1 2026, an estimated $4.89M.
Barclays first reported a position in Dynavax Technologies in Q2 2013 and held it in 48 quarters.
Barclays's Dynavax Technologies position peaked at $5.63M in Q4 2023.
1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.